A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK114

NCT05200273 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced or Metastatic Solid Tumors
Malignancy
Metastasis

Interventions

DRUG: AK114

Sponsor

Akeso